24 related news articles for Bronchopulmonary dysplasia (BPD)

Being born too soon exposes babies to many dangerous health conditions, and researchers are tackling one of them by finding out how magnesium sulphate can protect the health of the preterm brain.…  Read more

Shining a light on how the lung microbiome in the first days of life can affect the immune system for years to come, Hudson Institute researchers have taken an important first step in an increasingly relevant field of medical study.…  Read more

Hudson Institute researchers have conducted the first attempts to collect umbilical cord blood cells from very preterm babies, with a view to using them to reduce their increased risk of brain injury and disability.…  Read more

This is the time of year when we look back at what we have achieved and acknowledge the people who helped us make it happen. …  Read more

When baby Max arrived – early and in a hurry – no-one realised he would play a vital part in keeping other preterm babies healthy in the future.…  Read more

The long-term effects of newborn brain injuries are well known, so Professor Suzanne Miller’s dream is to be able to detect and treat those injuries in time to make a difference.…  Read more

An effective treatment is closer than ever for one of the most devastating conditions affecting premature babies, with researchers at Hudson Institute further refining their world-first method of treating BPD (Bronchopulmonary dysplasia).…  Read more

A treatment offering hope to parents of very premature babies is showing great promise, in the first worldwide stocktake of research into umbilical cord blood stem cells.…  Read more

Medical researchers are a big step closer to understanding the inflammatory responses in pre-term babies that can cause devastating heart and lung conditions including bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH).…  Read more

Research into a chronic lung disease in premature babies is leading Hudson Institute researchers to develop new protocols on how to treat infants with cell-based therapies. …  Read more

High-tech images have revealed for the first time that preterm babies on ventilators could be at risk of brain injury, leading to calls for caution during treatment.…  Read more

A cutting-edge new treatment for a fatal lung disease is one step closer thanks to a discovery by Hudson Institute stem cell therapy researchers.…  Read more

Associate Professor Rebecca Lim has been awarded $300,000 from the Victorian Medical Research Acceleration Fund to progress her laboratory’s research into a new regenerative medicine,…  Read more

Hudson Institute and Monash University researchers have assessed the long-term outcomes of their world-first study that used placental stem cells in premature babies with severe bronchopulmonary dysplasia, a form of chronic lung disease.…  Read more

New research into an anti-inflammatory drug for treating lung disease in pre-term babies has shown it also has the potential to prevent the disease’s subsequent complication, pulmonary hypertension (PH), a vascular condition that leads to heart failure and death in 50 per cent of cases.…  Read more

Associate Professor Rebecca Lim is now formally among the top scientists in Australia after being ranked the highest applicant in the industry category for the 2018 National Health and Medical Research Council (NHMRC) Career Development Fellowship Scheme. The award is given to the highest ranked applicant in the biomedical, clinical, industry and population health pillars…  Read more

A world-first therapy, developed at Hudson Institute of Medical Research and Monash University, using cells from the human placenta to repair the damaged lungs of premature babies, is giving hope to families of the most fragile infants like Harry Campbell. The results of a clinical trial at the Monash Children’s Hospital – the culmination of…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Claudia Nold, has received an academic promotion to Associate Professor from Monash University.…  Read more

Hudson Institute researchers have discovered a potential safe and effective treatment for bronchopulmonary dysplasia (BPD), which could save preterm babies from the severe lifelong effects of this incurable premature lung disease.…  Read more

The Fielding Foundation Fellowship 2017 has been jointly awarded to two outstanding immunology researchers at Hudson Institute, Dr Niamh Mangan, from the Centre for Innate Immunity and Infectious Diseases, and Associate Professor Marcel Nold, from The Ritchie Centre.…  Read more

Federal Member for Chisholm and former speaker, Anna Burke, and City of Monash Mayor, Cr Stefanie Perri, toured the Monash Health Translation Precinct’s (MHTP) new $84 million Translational Research Facility yesterday (Monday, February 15).…  Read more

Hudson Institute’s Dr Claudia Nold will use a competitive Heart Foundation Fellowship and Innovation Award to help develop new treatments for cardiopulmonary diseases in preterm babies.…  Read more

Hudson Institute’s Dr Claudia Nold has been awarded a prestigious Paul Korner Innovation Award from the Heart Foundation for her research into dangerous diseases associated with premature birth.…  Read more